Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3...
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights•This quadrivalent influenza vaccine was given to subjects 3 to 17 years of age. •Immunogenicity was determined by high seroconversion and seroconversion rates. •This vaccine is well tolerated with a favorable safety profile. •A quadrivalent vaccine may overcome the mismatches with influenza B strains.
Alternative Titles
Full title
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2425693680
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2425693680
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2020.03.048
